ArticleBritish journal of pharmacology2017

Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.

Ali Ryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.